A Meta-Analysis of Mortality and Major Adverse Cardiovascular and Cerebrovascular Events in Patients Undergoing Transfemoral Versus Transapical Transcatheter Aortic Valve Implantation Using Edwards Valve for Severe Aortic Stenosis

Nkomo, 2006, Burden of valvular heart diseases: a population-based study, Lancet, 368, 1005, 10.1016/S0140-6736(06)69208-8 Bonow, 2008, Circulation, 118, e523, 10.1161/CIRCULATIONAHA.108.190748 Panchal, 2013, A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis, Am J Cardiol, 112, 850, 10.1016/j.amjcard.2013.05.015 Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384 Latib, 2012, Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study, Am Heart J, 164, 910, 10.1016/j.ahj.2012.09.005 Bleiziffer, 2009, Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team, Eur J Cardiothorac Surg, 35, 615, 10.1016/j.ejcts.2008.12.041 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, e1000100, 10.1371/journal.pmed.1000100 Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 Al-Attar, 2009, Transcatheter aortic valve implantation: selection strategy is crucial for outcome, Ann Thorac Surg, 87, 1757, 10.1016/j.athoracsur.2009.03.047 Bosmans, 2011, Bruyne B De, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry, Interact Cardiovasc Thorac Surg, 12, 762, 10.1510/icvts.2010.253773 Dworakowski, 2010, Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study, Am Heart J, 160, 237, 10.1016/j.ahj.2010.05.014 Eltchaninoff, 2011, Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry, Eur Heart J, 32, 191, 10.1093/eurheartj/ehq261 Ewe, 2011, Kley F van der, Marsan NA, Weger A de, Tavilla G, Holman ER, Schalij MJ, Bax JJ. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach, Ann Thorac Surg, 92, 1244, 10.1016/j.athoracsur.2011.01.059 Gurvitch, 2011, Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients, Catheter Cardiovasc Interv, 78, 977, 10.1002/ccd.22961 Himbert, 2009, Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis, J Am Coll Cardiol, 54, 303, 10.1016/j.jacc.2009.04.032 Johansson, 2011, Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety, Ann Thorac Surg, 91, 57, 10.1016/j.athoracsur.2010.07.072 Lefèvre, 2011, One year follow-up of the multi-centre European PARTNER transcatheter heart valve study, Eur Heart J, 32, 148, 10.1093/eurheartj/ehq427 Nielsen, 2011, Single center experience with transcatheter aortic valve implantation using the Edwards SAPIENTM Valve, Scand Cardiovasc J, 45, 261, 10.3109/14017431.2011.575174 Osten, 2010, Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes, Catheter Cardiovasc Interv, 75, 475 Rodés-Cabau, 2010, Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience, J Am Coll Cardiol, 55, 1080, 10.1016/j.jacc.2009.12.014 Thomas, 2011, One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve, Circulation, 124, 425, 10.1161/CIRCULATIONAHA.110.001545 Thomas, 2010, Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve, Circulation, 122, 62, 10.1161/CIRCULATIONAHA.109.907402 Webb, 2009, Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes, Circulation, 119, 3009, 10.1161/CIRCULATIONAHA.108.837807 Wenaweser, 2011, Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes, Am Heart J, 161, 1114, 10.1016/j.ahj.2011.01.025 Zhao, 2012, Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: initial experience, Chin Med J (Engl), 125, 2807 Masson, 2009, Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications, JACC Cardiovasc Interv, 2, 811, 10.1016/j.jcin.2009.07.005 Onsea, 2012, First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions, Eurointervention, 8, 51, 10.4244/EIJV8I1A9 Généreux, 2012, Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of Aortic Transcatheter Valve) trial, J Am Coll Cardiol, 60, 1043, 10.1016/j.jacc.2012.07.003 Berry, 2007, Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System, Catheter Cardiovasc Interv, 70, 610, 10.1002/ccd.21282 Descoutures, 2008, Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly, Eur Heart J, 29, 1410, 10.1093/eurheartj/ehn081 Marcheix, 2007, Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis, J Thorac Cardiovasc Surg, 134, 1150, 10.1016/j.jtcvs.2007.07.031 Spargias K, Manginas A, Pavlides G, Khoury M, Stavridis G, Rellia P, Smirli A, Thanopoulos A, Balanika M, Polymeros S, Thomopoulou S, Athanassopoulos G, Karatasakis G, Mastorakou R, Lacoumenta S, Michalis A, Alivizatos P, Cokkinos D. Transcatheter aortic valve implantation: first Greek experience. Hellenic J Cardiol 2008; 49:397–407. Webb, 2006, Percutaneous aortic valve implantation retrograde from the femoral artery, Circulation, 113, 842, 10.1161/CIRCULATIONAHA.105.582882 Webb, 2007, Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis, Circulation, 116, 755, 10.1161/CIRCULATIONAHA.107.698258 Walther, 2007, Transapical minimally invasive aortic valve implantation: multicenter experience, Circulation, 116, I240, 10.1161/CIRCULATIONAHA.106.677237 Ye, 2009, Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients, J Thorac Cardiovasc Surg, 137, 167, 10.1016/j.jtcvs.2008.08.028 Zierer, 2008, The transapical approach for aortic valve implantation, J Thorac Cardiovasc Surg, 136, 948, 10.1016/j.jtcvs.2008.06.028 Leon, 2011, Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium, J Am Coll Cardiol, 57, 253, 10.1016/j.jacc.2010.12.005